Amgen obesity drug MariTide led to high discontinuation rates in trial
CHICAGO — Amgen’s monthly obesity candidate led to substantial weight loss but a high rate of side effects…
U.S. insurers to change approval process
UnitedHealthcare signage is displayed on an office building in Phoenix, Arizona, on July 19, 2023. Patrick T. Fallon…
FDA ouster of top gene therapy official reveals internal tensions
Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall…